The US E-Prescribing market is poised for exceptional growth, with revenue projected to reach $6,500 Million by 2025 and expected to surge to $19,200 Million by 2035. This strong revenue trajectory is attributed to mandates for electronic prescriptions, increased digital transformation initiatives, and expanded telemedicine utilization. In the past five years, compounded annual growth rates have accelerated, underscoring the sector's transition from pilot phases to mainstream adoption. Forward-looking investment in AI, blockchain, and interoperability solutions is expected to further boost revenues, as healthcare providers embrace comprehensive digital health ecosystems for improved patient outcomes.
Read More - https://bussinessinsights.com/research-report/us-e-prescribing
Hospitals represent the largest share of the US E-Prescribing market by application for 2025, reflecting their extensive digital health investments and compliance requirements. Clinics and pharmacies also play substantial roles, driven by the need for efficient prescription workflows and patient safety. The adoption of E-Prescribing in physician groups and research organizations continues to grow, supporting more informed medication decisions and streamlining research protocols. Hospitals' leadership in share is attributed to funding, federal mandates, and the centralization of patient care, while standalone clinics leverage E-Prescribing to improve care coordination and reduce medication errors.
Request Free Sample- https://bussinessinsights.com/request/telecommunication/us-e-prescribing
Who are the key players in US E-Prescribing industry?
Major players include Cerner Corporation, Allscripts Healthcare, DrFirst, Surescripts, and Athenahealth. These companies provide integrated EHR solutions, secure electronic prescription data transmission, and clinical decision support, helping improve medication management and compliance in the healthcare sector. Their platforms support large-scale hospital, pharmacy, and physician adoption of e-prescribing systems.
What is the US E-Prescribing growth?
The US E-Prescribing market is experiencing robust growth, with Surescripts reporting a 12% year-over-year increase in e-prescription transactions in 2023. This expansion is driven by regulatory mandates, interoperability improvements, and increased EHR adoption among healthcare providers and pharmacies.
Which segment accounted for the largest US E-Prescribing share?
The largest application segment in US E-Prescribing is the hospitals category. Hospital networks have embraced e-prescribing to reduce medication errors, streamline workflows, and meet government requirements for electronic prescribing of controlled substances, leading to higher adoption rates compared to smaller clinics and individual practices.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com